Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell division cycle 37 pseudogene 2 (CDC37P2) is a processed pseudogene present in the human genome[7][8]. Unlike its parent gene CDC37, which acts as a co-chaperone involved in signal transduction and protein kinase activity, CDC37P2 does not encode a functional protein and is not involved in any known cellular pathways or disease mechanisms. As a pseudogene, it lacks the biological and therapeutic significance characteristic of canonical protein targets. Clarification: This pseudogene should not be confused with CDC37 (Cell division cycle 37, HSP90 cochaperone), which is an important co-chaperone in signal transduction, protein folding, and kinase stabilization and is being investigated as a therapeutic target in oncology and other fields[1][2][3][5]. CDC37P2, by contrast, does not have such roles.
None (No therapeutics target this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell division cycle 37 pseudogene 2 (CDC37P2).